Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas-Reference-Cited by-同舟云学术

Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas

Published:2018-09-24 Issue:8 Volume:38 Page:1211-1224
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Arima Kota,Ohmuraya Masaki,Miyake Keisuke,Koiwa Mayu,Uchihara Tomoyuki,Izumi Daisuke,Gao Feng,Yonemura Atsuko,Bu Luke,Okabe Hirohisa,Imai Katsunori,Hashimoto Daisuke,Baba Yoshifumi,Chikamoto Akira,Yamashita Yo-ichi,Furukawa Toru^ORCID,Araki Kimi,Baba Hideo,Ishimoto Takatsugu^ORCID

Funder

Japan Society for the Promotion of Science

the Kanae Foundation for the Promotion of Medical Science, the Yasuda Medical Foundation and the Shinnihon Foundation of Advanced Medical Treatment Research

the Pancreas Research Foundation of Japan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0510-y.pdf

Reference45 articles.

1. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607–20.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

3. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755–68.

4. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67:1030–7.